Study shows high efficacy rate for fecal transplants

04/13/2012 | Medscape (free registration)

Fecal transplants resolved recurrent Clostridium difficile infection in more than 90% of patients, according to a report in the American Journal of Gastroenterology. Montefiore Medical Center researchers said the study included long-term follow-up with patients who had followed an average of five unsuccessful courses of traditional treatments without success before having fecal transplantation. "FMT is a rational, durable, safe, and acceptable treatment option for patients with recurrent C. difficile infection," Dr. Lawrence J. Brandt and colleagues wrote.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN